Heart cell injection for heart failure with reduced pumping function
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests whether injecting lab-grown heart cells into the heart can help people with heart failure whose heart pumps less than 40% of normal. It may help improve heart function and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart's pumping function (called ejection fraction) is 40% or less.
- You are in class II or III heart failure, meaning you have symptoms with mild activity or at rest.
- You do not have a pacemaker or an implantable defibrillator.
- You do not have heart failure caused by certain conditions like hypertrophic cardiomyopathy, amyloidosis, or congenital heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether injecting special heart cells (called HiCM-188) into the heart during bypass surgery can help improve heart function in people with advanced heart failure. The goal is to see if the cells can strengthen the heart muscle and help you feel better.
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
This trial tests whether injecting special heart muscle cells (made from stem cells) during a heart bypass or a heart pump surgery can help improve your heart's function. It is for people with severe heart failure who are already planning one of these surgeries.
This early-phase study tests a lab-made heart tissue (“engineered myocardium”) placed surgically to help the heart work better in people with advanced heart failure. It mainly checks safety first, and also looks for signs the patch can improve heart function in selected patients.
This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.
This trial tests a patch made from lab-grown heart cells that is placed on the heart during bypass surgery. It aims to improve heart function in people with very advanced heart failure who are already having bypass surgery.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.